A new study is suggesting a great number of individuals are self-treating problematic alcohol consumption with strong doses of LSD or psilocybin. The research rekindles interest in a strong vein of study from the 1950s and 1960s into LSD and alcoholism.
Continue Reading
Scientists in Germany are reporting successful results from the first phase of human clinical testing of a new Alzheimer’s drug. Following promising animal experiments the drug has initially now proved safe in human subjects and will soon move into Phase II clinical trials testing efficacy.
Continue Reading
In the 1990s, the lab of Frances Arnold showed how we can turn evolution to our advantage by manipulating microbes into evolving in a certain way. Now Arnold's team is using the technique to develop new antibiotics.
Continue Reading
After a tense 24 hours of vote counting it seems a Denver city initiative to essentially decriminalize personal use and possession of psilocybin magic mushrooms has been passed. With a margin of less than 2,000 votes Denver becomes the first city in the United States pass such a measure.
Continue Reading
Tuberculosis is currently curable, but the bacteria responsible for it are fast evolving resistance to our antibiotics, thwarting attempts to keep the disease under control. Scientists have found a new compound that can boost the power of existing antibiotics and even reverse the bugs’ resistance.
Continue Reading
A thousand-year-old pouch in Bolivia has revealed traces of several psychoactive compounds, indicating not only some of the earliest archeological evidence of ayahuasca use but also other intoxicants. The find suggests significant plant knowledge and a broad ancient plant trading network.
Continue Reading
Two studies are suggesting modulating activity of the hormone vasopressin may help treat the social impairments associated with autism. The two trials use different approaches but some experts are suggesting it is too early to conclude these hormones would be beneficial to all autistic subjects.
Continue Reading
Bacteria are quickly evolving resistances to antibiotics, to the extent that our best drugs might not work in the terrifyingly-near future. Now, researchers from Thomas Jefferson University have found a new way to weaken bacterial defenses, slowing down the development of antibiotic resistance.
Continue Reading
A new study has discovered a drug used to treat high blood pressure may also be beneficial for a variety of neurodegenerative diseases, including Parkinson’s and dementia. The research has only been verified in animals so far but the scientists are cautiously optimistic it will translate to humans.
Continue Reading
Part of cancer's cunning is its ability to spread around the body, so that doctors can rarely be sure they’ve killed it all. Now researchers have identified a drug that could help keep cancer contained in a dormant state – and best of all, that drug is already on the market for other purposes.
Continue Reading
See the stories that matter in your inbox every morning